CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale President and CEO sold 21,120 shares at an average $40.59 ($857,313)
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 10-K Report Annual Report
- 144 Insider Sale of Securities
- 4 Grant or award Chief Operating Officer acquired 5,184 shares (grant or award)
- 4 Grant or award See Remarks acquired 3,447 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 4,845 shares (grant or award)
- 4 Grant or award Director acquired 3,268 shares (grant or award)
- 4 Grant or award Exec. VP, Corporate Strategy acquired 3,964 shares (grant or award)
- 4 Grant or award President and CEO acquired 16,840 shares (grant or award)
- 4 Grant or award See Remarks acquired 2,152 shares (grant or award)
- 4 Grant or award See Remarks acquired 1,793 shares (grant or award)
- 8-K Event Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 8-K Event Results of operations
Page 6 of 39 · 774 filings